Endurant Capital Management LP - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 66 filers reported holding VIKING THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
Endurant Capital Management LP ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$336,422
-64.9%
20,754
-63.9%
0.29%
-40.2%
Q1 2023$957,125
-76.5%
57,485
-86.7%
0.49%
-70.2%
Q4 2022$4,070,529
+129.5%
433,035
+142.7%
1.65%
+135.8%
Q1 2019$1,774,000
+333.7%
178,448
+233.8%
0.70%
+224.5%
Q4 2018$409,000
-67.4%
53,466
-25.7%
0.22%
-61.3%
Q3 2018$1,254,000
+118.5%
71,977
+19.0%
0.56%
+124.1%
Q2 2018$574,000
+10.4%
60,499
-49.2%
0.25%
+28.4%
Q1 2018$520,000119,1000.19%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 150,000$2,613,0006.32%
Opaleye Management Inc. 825,000$14,371,0003.66%
Prosight Management, LP 274,410$4,780,0002.66%
SPHERA FUNDS MANAGEMENT LTD. 859,727$14,976,0001.72%
KNOTT DAVID M 236,600$4,122,0001.34%
Sio Capital Management, LLC 213,252$3,715,0001.28%
NEXTHERA CAPITAL LP 327,730$5,709,0001.09%
EAM Global Investors LLC 115,781$2,017,0000.82%
Nicholas Investment Partners, LP 580,028$10,104,0000.81%
Park West Asset Management LLC 1,269,107$22,108,0000.80%
View complete list of VIKING THERAPEUTICS INC shareholders